- Home
- WB vs TERN Comparison
WB vs TERN Comparison
Compare WB & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WB | TERN |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WB | TERN |
|---|---|---|
| Price | $10.44 | $29.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $14.00 | ★ $25.59 |
| AVG Volume (30 Days) | 1.1M | ★ 3.6M |
| Earning Date | 11-18-2025 | 11-10-2025 |
| Dividend Yield | ★ 15.74% | N/A |
| EPS Growth | ★ 20.16 | N/A |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $1,740,785,000.00 | N/A |
| Revenue This Year | $0.65 | N/A |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | $5.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.10 | $1.87 |
| 52 Week High | $12.96 | $30.25 |
Technical Indicators
Market Signals| Indicator | WB | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 72.14 |
| Support Level | $9.82 | $25.67 |
| Resistance Level | $10.51 | $29.51 |
| Average True Range (ATR) | 0.26 | 1.98 |
| MACD | 0.11 | -0.36 |
| Stochastic Oscillator | 90.61 | 88.39 |
Price Performance
Historical ComparisonAbout WB Weibo Corporation
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.